Ligand Pharmaceuticals Investor Relations Material

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on discovering and developing small molecule drugs that target GPCRs. Ligand has built a platform of proprietary technologies, primarily focused around the discovery and development of therapeutics that modulate G protein-coupled receptors. The company maintains an established proprietary library of over 7,000 small molecules designed to target a broad range of GPCRs in medical areas such as CNS, pain and inflammation, metabolic disorders, cancer and cardiovascular diseases. Headquartered in San Diego, California, Ligand has employees across its organization including R&D scientists, medicinal chemists and biologists who are dedicated to solving unmet medical needs through innovative drug discovery technologies.